Comparison of intravenous iron preparations in iron deficiency anemia in pregnancy
Not Applicable
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2018/12/016771
- Lead Sponsor
- Department of OBGY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant woman with confirmed moderate iron deficiency anemia (7to 10 gm/dl)
Singleton pregnancy
Gestational age between 28 to 34 week
Exclusion Criteria
Pregnant woman with anemia other than iron deficiency
Known case of allergy to iron injection
Multiple pregnancy
Hypertension
Diabetes mellitus
Chronic liver disease
Renal disorder
Cardiovascular disease
Thyroid disorder
Intestinal resection,bypass
Hemosiderosis
Hemochromatosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rise in hemoglobin and serum ferritin at 4 week and 8 week from baseline after receiving total dose of iron. <br/ ><br>Any untoward reaction during transfusion of drug.Timepoint: Rise in hemoglobin and serum ferritin at 4 week and 8 week from baseline after receiving total dose of iron. <br/ ><br>Any untoward reaction during transfusion of drug.
- Secondary Outcome Measures
Name Time Method Serum iron studies <br/ ><br>RBC indices <br/ ><br>Need for blood transfusion <br/ ><br>Perinatal outcome <br/ ><br>Postpartum hemorrhageTimepoint: At 4 week serum iron studies and RBC indices to be studied. <br/ ><br>At delivery perinatal outcome , postpartum hemorrhage, need for blood transfusion